# FDA 483 - Charles Redfern, MD - March 11, 2022

Source: https://www.globalkeysolutions.net/records/483/charles-redfern-md/f5dd3275-053f-4754-82ba-133f38978dfb

> FDA 483 for Charles Redfern, MD on March 11, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Charles Redfern, MD
- Inspection Date: 2022-03-11
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV

## Related Documents

- [483 - 2022-03-11](https://www.globalkeysolutions.net/records/483/charles-redfern-md/de57ea96-b1af-4715-aef4-54949e34625f)
- [483 - 2022-03-11](https://www.globalkeysolutions.net/records/483/charles-redfern-md/0a943d29-e1e3-40a1-bcdb-5d94276a0394)

## Related Officers

- [Christina D. Mello](https://www.globalkeysolutions.net/people/christina-d-mello/b523622e-d2dd-4ff6-9b2b-74b3134841de)

Company: https://www.globalkeysolutions.net/companies/charles-redfern-md/aaa97826-87aa-478e-be44-4a19e428c3d9

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6